China on Friday said it does not aim to engage in a space race with any nation, responding to comments by US President Donald Trump that Washington is now “dominating space” after once “losing it to ...

When Ken Johnson noticed items around his home knocked over and damaged, he set up cameras. For months, he waited for answers. Then, last week, an uninvited guest emerged from under his Altadena, ...

GSK has paid $50 million upfront to partner with LTZ Therapeutics on myeloid cell engagers, expanding its cancer pipeline to cover a modality that has attracted Eli Lilly, Novartis, Pfizer and Sanofi.

Welcome to Edition 8.20 of the Rocket Report! For the second week in a row, Blue Origin dominated the headlines with news about its New Glenn rocket. After a stunning success November 13 with the ...